Cytokinetics
Trade Cytokinetics 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About CYTK
Cytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining. The firm is developing small molecule drug candidates specifically engineered to impact muscle function and contractility.
CYTK Key Statistics
Stock Snapshot
With a market cap of 9.71B, Cytokinetics(CYTK) trades at $78.06. The stock has a price-to-earnings ratio of -11.51.
During the trading session on 2026-05-21, Cytokinetics(CYTK) shares reached a daily high of $79.09 and a low of $77.60. At a current price of $78.06, the stock is +0.6% higher than the low and still -1.3% under the high.
Trading volume for Cytokinetics(CYTK) stock has reached 1.78M, versus its average volume of 3.49M.
Over the past 52 weeks, Cytokinetics(CYTK) stock has traded between a high of $80.20 and a low of $29.81.
Over the past 52 weeks, Cytokinetics(CYTK) stock has traded between a high of $80.20 and a low of $29.81.
CYTK News
New insider activity at Cytokinetics ( (CYTK) ) has taken place on May 20, 2026. Unlock hedge fund-level data and powerful investing tools for smarter, sharper...
Advertisement Event overview and recent stock move Cytokinetics (CYTK) stock has recently been in focus, with shares closing at $78.77. Investors are weighing...
Cytokinetics ((CYTK)) has held its Q1 earnings call. Read on for the main highlights of the call. Claim 55% Off TipRanks Unlock hedge fund-level data and powerf...
Analyst ratings
87%
of 23 ratingsMore CYTK News
Cytokinetics, Incorporated recently reported positive new Phase 3 data for its cardiac myosin inhibitor MYQORZO (aficamten) across obstructive and non-obstructi...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.